A Novel Statistical Test for Treatment Differences in Clinical Trials using a Response Adaptive Forward Looking Gittins Index Rule

11/06/2020
by   Helen Yvette Barnett, et al.
0

The most common objective for response adaptive clinical trials is to seek to ensure that patients within a trial have a high chance of receiving the best treatment available by altering the chance of allocation on the basis of accumulating data. Approaches which yield good patient benefit properties suffer from low power from a frequentist perspective when testing for a treatment difference at the end of the study due to the high imbalance in treatment allocations. In this work we develop an alternative pairwise test for treatment difference on the basis of allocation probabilities of the covariate-adjusted response-adaptive randomization with forward looking Gittins index rule (CARA-FLGI). The performance of the novel test is evaluated in simulations for two-armed studies and then its applications to multi-armed studies is illustrated. The proposed test has markedly improved power over the traditional Fisher exact test when this class of non-myopic response adaptation is used. We also find that the test's power is close to the power of a Fisher exact test under equal randomization.

READ FULL TEXT

page 1

page 2

page 3

page 4

research
03/14/2018

Familywise error control in multi-armed response-adaptive trials

Response-adaptive designs allow the randomization probabilities to chang...
research
06/15/2018

Imbalanced Randomization in Non-Inferiority Trial

Randomization is a common technique used in clinical trials to eliminate...
research
04/16/2019

Robust Response-Adaptive Randomization Design

In clinical trials, patients are randomized with equal probability among...
research
06/15/2018

Imbalanced Randomization in Non-Inferiority Trials

Randomization is a common technique used in clinical trials to eliminate...
research
09/29/2021

A Markov Decision Process for Response-Adaptive Randomization in Clinical Trials

In clinical trials, response-adaptive randomization (RAR) has the appeal...
research
02/08/2022

Validity of tests for time-to-event endpoints in studies with the Pocock and Simon covariate-adaptive randomization

In the presence of prognostic covariates, inference about the treatment ...
research
05/01/2020

Response-adaptive randomization in clinical trials: from myths to practical considerations

Response-adaptive randomization (RAR) is part of a wider class of data-d...

Please sign up or login with your details

Forgot password? Click here to reset